What renaming PCOS to PMOS could mean for the future of women’s health
Get the Well Enough newsletter with Harry Bullmore for tips on living a healthier, happier and longer life Get the Well Enough email with Harry Bullmore Get the Well Enough email with Harry Bullmore “Hopeful,” “excited” and “helpful” for the future of women’s health — these are just some of the words expressed by the team that worked together for more than a decade to change the name polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS). PMOS is a chronic condition associated with diabetes, heart disease, depression, infertility, pregnancy complications and a general decreased quality of life. It affects an estimated one in eight women worldwide, and about one in 10 Canadian women, yet the World Health Organization estimates that 70%t of those affected have never received a diagnosis. Why the name has changed The term PCOS was inaccurate, because there is no increase in abnormal ovarian cysts. Rather, the hallmark of this condition is follicles, or little fluid sacs, around partly developed eggs, which are caused when development is disrupted by a …







